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ABSTRACT
Dissection of the cavernous nerves during radical prostatectomy for
prostate cancer eliminates spontaneous erections. Using the rat as
an experimental model, we compared the regenerative capacity of
autologous nerve grafts and Schwann-cell-seeded nerve guides. After
bilateral excision of cavernous nerve segments, cavernous nerves
were reconstructed using unseeded silicon tubes, nerve autografts and
silicon tubes seeded with either Glial-cell-line-derived (GDNF)-
overexpressing or green fluorescent protein (GFP)-expressing
Schwann cells (SCs) (16 study nerves per group). Control groups
underwent either a sham operation or bilateral excision of cavernous
nerve segments without repair. After 12 weeks erectile function was
assessed by neurostimulation and intracavernous pressure (ICP)
measurement. The reconstructed nerve segments were excised and
histologically analyzed. We demonstrated an intact erectile response
upon neurostimulation in 25% (4/16) of autologous nerve grafts, in 50%
(8/16) of unseeded tubes, in 75% (12/16) of the Schwann-cell–GFP
group and in 93.75% (15/16) of the GDNF group. ICP was significantly
increased when comparing the Schwann-cell–GFP group with nerve
autografts, unseeded conduits and negative controls (P<0.005). In
conclusion, Schwann-cell-seeded scaffolds combined with
neurotrophic factors are superior to unseeded tubes and autologous
nerve grafts. They present a promising therapeutic approach for the
repair of erectile nerve gaps.
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INTRODUCTION
Neurogenic erectile dysfunction resulting from injured cavernous
nerves during surgery still represents a frequent complication after
radical prostatectomy for prostate cancer. Whereas current research
strategies have focused on pharmacological methods, (e.g.
phosphodiesterase type 5 inhibitors) so as to preserve the
hemodynamic mechanisms of penile erection, there are no
interventions to support cavernous nerve regeneration following
radical prostatectomy. Schwann cells (SCs) are the main glia of
peripheral nerves and have a key role in nerve regeneration
(Gordon and Borschel, 2016; Wang et al., 2015; Jessen and Mirsky,
2016). Adherent molecules on the surface of SCs can secrete
extracellular matrix and guide the growth of axons. Neurotrophic
factors secreted by SCs might be the most important factors in the
microenvironment for regenerating axons (Santos et al., 2016).
Growth factors enhance axonal regrowth and promote neuron
survival. This regenerative capacity is particularly important in the
delayed repair of longer nerve gaps, such as cavernous nerve injury
caused by radical prostatectomy. There are various treatment
strategies in animal models for the repair of injured cavernous
nerves, including mesenchymal stem cells, immunophilins and
neurotrophic factors. GDNF has been shown in vitro to promote the
outgrowth and survival of autonomic nerves including penile
erection-inducing autonomic neurons (Palma and Keast, 2006;
Laurikainen et al., 2000). Several in vivo studies have demonstrated
the ability of the GDNF family to enhance functional repair of
injured cavernous nerves (Bella et al., 2007; Kato et al., 2007).
Therefore, we chose GDNF for this study.
Following nerve injury, SCs might not release enough
neurotrophic factors to preserve neuron survival. As neuronal
repair mechanisms might take a longer period of several months,
previous work has proposed the delivery of growth factors in
peripheral nerve repair (Qin et al., 2016). Numerous investigations
have demonstrated that cavernous nerves can be successfully
repaired using autologous nerve grafts and artificial conduits. The
addition of neurotrophic factors and SCs has been shown to further
promote nerve regeneration (Xu et al., 2016; Hood et al., 2009).
We previously demonstrated that conduits seeded with syngenic
SCs successfully bridge transected cavernous nerves (May et al.,
2004). The regenerative capacity can be enhanced by the genetic
modification of SCs to overexpress GDNF (May et al., 2008).
The aim of the current study was to investigate and compare
different methods of cavernous nerve grafting. Rat cavernous nerve
defects were reconstructed by conduits seeded with GDNF-
overexpressing SCs. The functional results were compared with
those of silicon tubes filled with GFP-expressing SCs, unseeded
tubes and nerve autografts.
RESULTS
Achieving a clear, visible erection with a full increase in shaft length
on neurostimulation was interpreted as restored erectile function.
While all animals of the sham group revealed an intact erectile
response, rats after bilateral nerve resection without interposition
grafting (control group) showed no inducible erections, confirming
that this animal model is reliable (Fig. 1, Table 1).Received 10 June 2016; Accepted 3 October 2016
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Neurostimulation led to full erections in 25% (4/16) of rats with
autologous nerve grafts, whereas unseeded tubes restored erection
in 50% (8/16) of rats with reconstructed nerves (Fig. 1, Table 1).
SC-seeded guidance tubes showed the best results, achieving
erections in 94% (15/16) of rats in the GDNF and 75% (12/16) in
the GFP group. Intact erectile response promoted by GDNF-
transduced grafts was significantly superior to nerve autografts
(P<0.001).
Neurostimulation with measurement of ICP was used to quantify
erectile function. GDNF- and GFP–SC-seeded conduits led to the
highest increase of this parameter (Fig. 2, Table 2). ICP was
significantly increased comparing the GFP group with unseeded
tubes (P=0.004), nerve autografts (P<0.001) and negative controls
(P<0.001). Both nerve autografts and unseeded conduit rats
exhibited a significantly lower ICP increase compared with the
GFP group.
Histological analysis of the nerve grafts showed that the
regenerated nerves were usually localized in the center of the
silicon tube encircled by an acellular substance that filled the area
between the regenerated nerve and the inner conduit wall (Fig. 3A,B).
Special stains show regenerating nerve fibers including myelinated
axons within the entire regenerate (Fig. 3C,D).
DISCUSSION
Recovery of cavernous nerve injury following radical
prostatectomy for prostate cancer is often poor despite nerve-
protecting techniques. Deliberate excision of the neurovascular
bundles for oncological reasons also leads to permanent erectile
dysfunction. Autologous sural nerve grafts have been used to
repair this injury with insufficient results (White and Kim, 2009).
Moreover, they are associated with specific morbidity resulting
Fig. 1. Recovery of erectile function after bilateral nerve ablation and reconstruction. At 12 weeks, rats were re-operated and erectile function was
evaluated. On direct electrical nerve stimulation, erectile response was analyzed and counted for sham-operated, excision-operated, unseeded tubes, nerve
autograph (NA), GDNF-overexpressing-SC-seeded tube (GDNF) and GFP–SC-seeded tube (GFP) treatments.
Table 1. Recovery of erectile function in response to electrical
stimulation
Groups Erections (n) Erections (%) P-value
Sham vs excision 16/0 100/0 0.000
Sham vs unseeded tubes 16/8 100/50 0.002
Sham vs nerve autografts 16/4 100/25 0.000
Sham vs GDNF 16/15 100/93,75 1.000
Sham vs GFP 16/12 100/75 0.101
Excision vs unseeded tubes 0/8 0/50 0.002
Excision vs nerve autografts 0/4 0/25 0.101
Excision vs GDNF 0/15 0/93,75 0.000
Excision vs GFP 0/12 0/75 0.000
Unseeded tubes vs nerve
autografts
8/4 50/25 0.273
Unseeded tubes vs GDNF 8/15 50/93,75 0.015
Unseeded tubes vs GFP 8/12 50/75 0.273
Nerve autografts vs GDNF 4/15 25/93,75 0.000
Nerve autografts vs GFP 4/12 25/75 0.012
GDNF vs GFP 15/12 93,75/75 0.333
Using Fisher’s exact test (two-sided) and Bonferroni’s correction for multiple
testing. Only P-values <0.05/15=0.003 were regarded as significant.
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from a second surgical intervention. Artificial nerve grafts might
avoid these deficits.
We therefore looked for alternative nerve-growth-promoting
strategies. Using a reliable animal model that leads to complete loss
of erectile function unless the nerves are reconstructed, we
compared the results achieved by nerve autografts, unseeded
silicon guidance channels, SC-seeded nerve guides and conduits
seeded with SCs overexpressing GDNF. To our knowledge, this is
the first study comparing these modalities for the reconstruction of
erectile nerves. This study shows that SC-seeded nerve guides
effectively restore cavernous nerve gaps in rodents. We demonstrate
that a simple artificial peripheral nerve can be created by placing
SCs, and even neurotrophic-factor-overexpressing SCs, within a
silicon tube to promote the regeneration of cavernous nerves. We
have found that this strategy clearly expands the clinical potential
of unseeded tubes, permitting the repair of the majority of injured
cavernous nerves. Whereas nerve autografts led to the restoration of
erectile function in 25% of grafted nerves, GFP- and GDNF-
transduced SC grafts led to success rates of 75% and 94%,
respectively. ICPmeasurement supports these findings showing that
the GFP and GDNF group led to the best results, whereas ICP levels
were low for the nerve autograft and unseeded tube groups.
Histological findings confirm recent data of our group showing that
GDNF accelerates cavernous nerve regeneration, enhancing the
number and maturation of regenerated axons (May et al., 2008).
Even unseeded conduits led to better results than nerve autografts,
in which intraneural scarring might inhibit axonal regrowth.
Previous histological findings demonstrated that the architecture
of regenerating nerves within silicon tubes often resembles the intact
axonal structure in contrast to nerve autografts, which showed only
sparse regenerating minifascicles (May et al., 2004). Contrary to
artificial delivery systems, SCs are able to react to changes of their
environment by secretion of multiple growth factors. A major
disadvantage of autologous SCs, however, is the delay caused by
culture and purification of SCs before clinical use.
The unique regenerative capacity of SCs declines after longer
intervals of denervation. The loss of axonal contact during
Fig. 2. On direct electrical nerve stimulation, erectile response was quantified by measurement of intracavernous pressure increase. Values represent
mean±standard error of the mean (s.e.m.). The best restoration of this parameter was achieved by GDNF- and GFP-transduced SC grafts (Kruskal–Wallis-
ANOVA: all groups P<0.001). Both nerve autografts (NA) and unseeded conduits exhibited a significantly lower ICP increase compared with SC-seeded conduits
(GFP group).
Table 2. Measurement of ICP increase comparing the different
treatment groups
Sham Excision Unseeded tubes NA GDNF
Excision <0.001
Unseeded tubes 0.001 1
Nerve autografts <0.001 1 1
GDNF 1 0.0015 0.342 0.02
GFP 1 <0.001 0.004 <0.001 1
Statistical analysis was realized by ANOVA followed by Bonferroni–Dunn’s
test.
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peripheral nerve damage induces a change from a myelinating to a
non-myelinating growth-supportive phenotype with enhanced
expression of neurotrophic factors and their receptors (Jessen and
Mirsky, 2016; Sulaiman and Gordon, 2013; Wood and Mackinnon,
2015). The upregulation of the so-called regeneration-associated
genes (RAGs) is transient and there is a limited time window during
which SCs enable axonal regrowth.
Höke et al. (2002) examined the changes in the expression pattern
of the GDNF family of growth factors in chronically denervated rat
sciatic nerves. Only GDNF mRNA expression was rapidly
upregulated in SCs as early as 48 hours after denervation. This
upregulation peaked at 1 week and then declined to minimal levels
by 6 months of denervation. This study suggests that the limited
ability of SCs to support chronically injured neurons with
neurotrophic factors might be one of the main reasons for failed
regeneration. Therefore, transplantation of gene-modified SCs that
produce the needed types of neurotrophic factors represents an
effective strategy to overcome this functional deficit.
Several studies provide evidence for the successful use of
neurotrophic factor gene therapy in humans. Treatment with
adenovirus encoding GDNF, BDNF or transforming growth factor
β2 (TGFβ2) significantly prevented the degeneration of facial motor
neurons in individuals with facial nerve lesions (Sakamoto et al.,
2003). Adenoviral GDNF transfer promoted laryngeal function
recovery after recurrent laryngeal nerve injury (Araki et al., 2006) and
stereotactic gene delivery for neurotrophic factors was well tolerated
in individuals with advanced Alzheimer’s (nerve growth factor; Rafii
et al., 2014) and Parkinson’s disease (neurturin; Marks et al., 2016).
There are major limitations in neurotrophic factor gene therapy
for peripheral nerve lesions, as it might provoke uncontrolled and
misdirected growth of axons, hypersensitivity and neuropathic pain
(Hoyng et al., 2015). Therefore, animal studies must first provide
evidence that dose and timing of neurotrophic factor gene delivery is
effectively controlled before this strategy can be tested in patients
with peripheral nerve injuries.
Adequate axonal guidance for injured peripheral nerves could be
accomplished by means of micro- or nanostructured conduits
combined with cellular delivery of neurotrophic factors. The
supportive effect of these cells might prolong the time window
for axonal regeneration and improve the rate of functional
restoration even in chronic cases.
MATERIALS AND METHODS
In vitro experiments
Sciatic nerve fragments from adult male Fischer rats were used for isolation
and culture of SCs as previously described (May et al., 2004). Vectors
encoding the full sequence of rat GDNF were produced as published by
Blesch and Tuszynski (2003). Retroviral vectors expressing GDNF derived
from Moloney leukemia virus were used for transduction of SCs in vitro.
Whereas effective transduction in vitrowas tested by GDNF-specific ELISA
(Promega, Madison, WI, USA), we confirmed in vivo GDNF presence by
immunhistochemical analysis (May et al., 2008).
We used non-biodegradable silastic nerve guides (length, 5 mm; inner
diameter, 0.51 mm; outer diameter 0.94 mm) for interposition grafting. The
tubes were filled with the GDNF-SC suspension (cell quantity 25,000 cells/ml)
as previously described (May et al., 2008).
Animal experiments
Forty-eight adult male Fischer 344 rats (250-350 g) were randomized into
six groups of eight each (16 study nerves). The bilateral cavernous nerves
were transected to create a 5 mm defect, which was immediately
reconstructed using unseeded (empty) silicon tubes, nerve autografts,
tubes seeded with either GFP- or GDNF-transduced SCs (16 study nerves
per group; Table 3). The ipsilateral genitofemoral nerve (7 mm segment)
was used for interposition grafting between the transected cavernous nerve
ends as previously published (May et al., 2004).
Further animals were either sham-operated or underwent bilateral nerve
excision without repair (control groups, 16 study nerves each). The surgical
procedures were described previously (May et al., 2004, 2008).
All rats underwent a relaparotomy once after 12 weeks and were euthanized
afterwards. Evaluation included neurostimulation of the proximal cavernous
nerves over an intact nerve segment and measurement of both intracavernous
pressure (ICP) andmeanarterial bloodpressure (MAP) as describedpreviously
(May et al., 2004). All surgical procedures including reexploration and
electrostimulationwere approved by the local ethics committee anddone in full
accordance with national and institutional regulations.
Histological analysis
The reconstructed nerves were harvested, dissected at mid-regenerate level,
fixed and embedded as previously published (May et al., 2008). Semithin
Fig. 3. Microscopic transverse sections of nerve regenerates after
12 weeks. (A,B) Intratubular regenerates (black brackets) after entubulization
with (A) GFP- and (B) GDNF-transduced SCs. (C,D) Detailed histological
studies are required to identify regenerating nerve fibers (framed by red
dashed line) amongst the entire regenerate (green dashed line) that also is
composed of fibrovascular tissue and large blood vessels (BV). Special stains
were used to highlight myelinated fibers (D, black rings) within theminifascicles
(framed by red dashed line). A,B,C: Azure II Methylene Blue-Safranin; D:
p-phenylendiamine.
Table 3. Flowchart depicting the design of the study and the different
treatment groups




















Sham 16 Sham operation without
nerve injury
1-3
Excision 16 Bilateral nerve excision
without reconstruction
1-3
Evaluation parameters: 1, electrical nerve stimulation; 2, intracavernous
pressure recording; 3, histological analysis of excised nerve segments
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sections (0.5 µm) were stained with Azure Blue-Safranin and
p-phenylendiamine and then analyzed for regenerating axons and the
fascicular formation.
Data analysis
Data are presented as mean±s.e.m. Groups are compared by the chi-square
and Fisher exact tests. Intracavernous pressure and systemic blood pressure
were analyzed by using nonparametric Kruskal–Wallis ANOVA followed
by Bonferroni–Dunn’s test for individual between-group comparisons at the
P<0.05 level of significance.
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